Known as 'QDenga,' this second-generation vaccine was developed by the Takeda Pharmaceutical Co.Speaking at The Manila Times' 'Reel Times,' Philippine Medical Association president Dr. Hector Santos said the Food and Drug Administration was still trying to collate the studies for this vaccine, which has been used in Brazil and some Southeast Asian and African countries.
Meanwhile, Foundation for Vaccination executive director Dr. Lulu Bravo said safety was the first essential principle for vaccines, and while they were still following up on the clinical tests for the past eight years, they said the safety profile of the vaccine was 'very good' and had no concerns at all in giving it.Bravo said that in the trials for the vaccine, their group enrolled 4- to 16-year-olds.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: BusinessMirror - 🏆 19. / 59 Read more »